Abstract
Glycosylation is critical to megakaryocyte (MK) and thrombopoiesis in the context of gene mutations that affect sialylation and galactosylation. Here, we identify the conserved B4galt1 gene as a critical regulator of thrombopoiesis in MKs. β4GalT1 deficiency increases the number of fully differentiated MKs. However, the resulting lack of glycosylation enhances β1 integrin signaling leading to dysplastic MKs with severely impaired demarcation system formation and thrombopoiesis. Platelets lacking β4GalT1 adhere avidly to β1 integrin ligands laminin, fibronectin, and collagen, while other platelet functions are normal. Impaired thrombopoiesis leads to increased plasma thrombopoietin (TPO) levels and perturbed hematopoietic stem cells (HSCs). Remarkably, β1 integrin deletion, specifically in MKs, restores thrombopoiesis. TPO and CXCL12 regulate β4GalT1 in the MK lineage. Thus, our findings establish a non-redundant role for β4GalT1 in the regulation of β1 integrin function and signaling during thrombopoiesis. Defective thrombopoiesis and lack of β4GalT1 further affect HSC homeostasis.
Funding Information
  • U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01 HL134829, R01 AI140736, R01 HL089224, P01 HL107146, K12 HL141954)
  • American Society of Hematology (Bridge Grant)
  • U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
  • U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
  • U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
  • U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute

This publication has 71 references indexed in Scilit: